Glioblastoma Archive - Seite 14 von 24 - IOZK

Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme

2013-06-21/in Dendritic Cells, Glioblastoma, International Publications /von 2013-06-21 / Cancer Treat. Rev. 2013 Dec;39(8):891-907

Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL.

2013-06-03/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3100)

Outcome of an advanced anaplastic astrocytoma patient treated with Newcastle disease viral (NDV) oncolytic therapy.

2013-05-31/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e13029)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates

2013-03-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401

Vaccine strategies for glioblastoma: progress and future directions

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / Immunotherapy 2013 Feb;5(2):155-67

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / J. Immunother. 2013 Feb;36(2):152-7

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

2012-12-27/in Dendritic Cells, Glioblastoma, International Publications /von 2012-12-27 / BMC Cancer 2012 Dec;12:623

Immunotherapy with tumor vaccines for the treatment of malignant gliomas

2012-12-01/in Glioblastoma, International Publications /von 2012-12-01 / Curr Drug Discov Technol 2012 Dec;9(4):237-55

Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.

2012-06-04/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)

The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with glioblastoma.

2012-06-02/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2084)